Subsequent evaluation of biochemical parameters relevant to T2D phenotypes in HFD mice treated with BLINK11 and BLINK15 revealed a rescue in weight gain, improved glucose tolerance, and reduced insulin levels compared to the untreated HFD group. This evidence concerns the gene INS and glucose measurement.